| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/31/2006 | WO2006031644A3 Immobilized probes and methods of detecting conformationally altered prion proteins |
| 08/31/2006 | WO2006029176A3 Cancer-testis antigens |
| 08/31/2006 | WO2006024694A3 Peptide inhibitors of hk2 and their use |
| 08/31/2006 | WO2005124344A3 Method for detecting anti-transglutaminase antibodies in a saliva sample |
| 08/31/2006 | WO2005075453A9 Linker compound, ligand complex and process for producing them |
| 08/31/2006 | WO2005047307A3 Il-18 binding proteins |
| 08/31/2006 | WO2005032455A3 Combinatorially selected phosphorodithioate aptamer targeting ap-1 |
| 08/31/2006 | WO2005016281A3 Diagnosis and treatment of malignant neoplasms |
| 08/31/2006 | WO2005015159A3 Methods for modulating a drug-related effect or behavior |
| 08/31/2006 | WO2005003308A3 Biological data set comparison method |
| 08/31/2006 | US20060195938 Polynucleotides encoding insect acetyl coenzyme-A carboxylase and uses thereof |
| 08/31/2006 | US20060195917 Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype |
| 08/31/2006 | US20060195268 Method for determining the titer of biological agents in living target cells |
| 08/31/2006 | US20060195133 Tissue penetration device |
| 08/31/2006 | US20060195132 Tissue penetration device |
| 08/31/2006 | US20060195131 Tissue penetration device |
| 08/31/2006 | US20060195130 Tissue penetration device |
| 08/31/2006 | US20060195129 Tissue penetration device |
| 08/31/2006 | US20060195047 Sampling module device and method |
| 08/31/2006 | US20060194834 Serotonin receptor antagonist; psychological disorders; Alzheimer's disease |
| 08/31/2006 | US20060194778 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 08/31/2006 | US20060194751 Streptococcus pyogenes antigens |
| 08/31/2006 | US20060194734 Cardiac muscle function and manipulation |
| 08/31/2006 | US20060194715 Proteins encoded by ble genes and antibiotics from the bleomycin family |
| 08/31/2006 | US20060194346 Surface plasmon-field-enhanced diffraction sensor |
| 08/31/2006 | US20060194345 Concentration measuring method, concentration measuring kit, and sensor chip for use in the method |
| 08/31/2006 | US20060194344 Plasmon resonant structure, controlling method thereof, and a metallic domain manufacturing method |
| 08/31/2006 | US20060194343 comprising immobilized 1-acetato-4-benzyl-1,4,7-triazacyclononane chelated to a metal ion ; can be regenerated to bind same or different molecules by washing surface of solid support with imadazole, acidic pH or addition of a Lewis base ligand; metal ion can be changed using EDTA |
| 08/31/2006 | US20060194342 Agglutination based sample testing device |
| 08/31/2006 | US20060194341 Library of compounds labelled with radiosotope |
| 08/31/2006 | US20060194340 Also, utilization of mass spectrometry (e.g., Surface Enhanced Laser Desorption Ionization, Maldi Qq TOF, MS/MS, TOF TOF, ESI-Q-TOF or ION-TRAP) to elucidate particular indicative or predictive biopolymer markers |
| 08/31/2006 | US20060194339 Isolated biopolymer marker peptide; using mass spectrometry to determine markers predictive of insulin resistance |
| 08/31/2006 | US20060194338 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 08/31/2006 | US20060194337 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 08/31/2006 | US20060194336 Test paper and porous membrane |
| 08/31/2006 | US20060194332 Gas sensor and method of fabricating a gas sensor |
| 08/31/2006 | US20060194329 Sample analyzing method and sample analyzing program |
| 08/31/2006 | US20060194328 Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins |
| 08/31/2006 | US20060194327 On-chip magnetic particle sensor with improved snr |
| 08/31/2006 | US20060194326 Method of lipoprotein analysis and analytical program |
| 08/31/2006 | US20060194306 System for gel electrophoretic immunoassay |
| 08/31/2006 | US20060194293 Rb1 gene induced protein (rb1cc1) and gene |
| 08/31/2006 | US20060194291 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 08/31/2006 | US20060194290 Polypeptide variants with altered effector function |
| 08/31/2006 | US20060194287 Chemokine-binding protein and methods of use |
| 08/31/2006 | US20060194283 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194282 Contains at least one mutation that reduces or eliminates the ability of the fluorescent protein to oligomerize; determining the pH of a sample, presence of an enzyme, and activity of an enzyme by variation of fluorescence; kits |
| 08/31/2006 | US20060194281 decrease inhibit or prevent viral propagation or screening of compounds impaction on the expression of shorter form core+1 protein; antiviral agents |
| 08/31/2006 | US20060194270 Method for measuring oxidized ldl-crp complex and measurement kit |
| 08/31/2006 | US20060194269 Polysaccharide structure and sequence determination |
| 08/31/2006 | US20060194268 Method for measuring spinorphin |
| 08/31/2006 | US20060194267 Secifically a Borrelia, Babesia, or Ehrlichia; enzyme-linked immunoassay test, blot analysis, or Multi-Peptide ELISA Blot analysis of antibody levels; Lyme Disease |
| 08/31/2006 | US20060194266 Use of protein RLA-0 as a marker for colorectal cancer |
| 08/31/2006 | US20060194265 Novel therapeutic targets in cancer |
| 08/31/2006 | US20060194264 Affinity based system for detecting particulates in a fluid |
| 08/31/2006 | US20060194263 Small molecule mediated, heterogeneous, carbon nanotube biosensing |
| 08/31/2006 | US20060194262 P27 ubiquitination assay and methods of use |
| 08/31/2006 | US20060194261 Methods for determining cellular response to stimuli |
| 08/31/2006 | US20060194260 Screening assays for cannabinoid-ligand-type modulators of gpr55 |
| 08/31/2006 | US20060194259 Method for isolating an allosteric effector of a receptor |
| 08/31/2006 | US20060194257 MECP2E1 gene |
| 08/31/2006 | US20060194256 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 08/31/2006 | US20060194255 Parallel patch clamp system |
| 08/31/2006 | US20060194254 Method for identifying optimal binding ligands to a receptor |
| 08/31/2006 | US20060194253 A transfected cell line and a method using the same for the high throughput screening for inhibitors of the t-type calcium channel alpha-1h |
| 08/31/2006 | US20060194252 patterning a film on the substrate by imprint lithography to define first regions and second regions andfunctionalizing the exposed second regions to provide immobilized target-molecule-capturing functionality |
| 08/31/2006 | US20060194251 Method of fixing low-molecular compound to solid-phase support |
| 08/31/2006 | US20060194248 Method of measuring human CYP3A inducibility |
| 08/31/2006 | US20060194245 Expression miniarrays and uses thereof |
| 08/31/2006 | US20060194238 Peripheral neuropathy diagnosis |
| 08/31/2006 | US20060194235 HLJ1 gene expression |
| 08/31/2006 | US20060194230 Genetic markers associated with benign prostatic hyperplasia |
| 08/31/2006 | US20060194229 Cancer markers and detection methods |
| 08/31/2006 | US20060194227 Heteroduplex tracking assay |
| 08/31/2006 | US20060194226 Modified cyanovirin protein |
| 08/31/2006 | US20060194219 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194218 Inducible fluorescence assay |
| 08/31/2006 | US20060194212 Treatment of AIDS |
| 08/31/2006 | US20060194211 Methods for prognosis and treatment of solid tumors |
| 08/31/2006 | US20060194210 Novel therapeutic targets in cancer |
| 08/31/2006 | US20060194204 Gene expressed in prostate cancer, methods and use thereof |
| 08/31/2006 | US20060194197 Biosensors utilizing dendrimer-immobilized ligands and their use thereof |
| 08/31/2006 | US20060194195 Multiple antigenic peptide assay for detection of hiv or siv type retroviruses |
| 08/31/2006 | US20060194030 Methods for identification and verification |
| 08/31/2006 | US20060193871 transmission and, or amplification of signal; oral or enteric administering, dissolving, absorption; peptide yy; obesity therapy |
| 08/31/2006 | US20060193870 Compositions and methods for the therapy and diagnosis of colon cancer |
| 08/31/2006 | US20060193868 graphitic nanotubes substituted with chemical moieties or upon which certain cyclic compounds are adsorbed; complex structures comprised of such functionalized fibrils linked to one another; introducing functional groups onto the surface of such fibrils |
| 08/31/2006 | US20060193864 Conversion of apoptotic proteins |
| 08/31/2006 | US20060193863 Compositions and methods for diagnosing and treating prostate cancer |
| 08/31/2006 | US20060193852 immunotherapy, preferably against B-cell malignancies such as non-Hodgkin lymphoma; single-chain multifunctional polypeptides comprising at least two binding sites specific for the CD19 and CD3 antigen; domains are arranged in the order VLCD19-VHCD19-VHCD3-VLCD3; vector; cell |
| 08/31/2006 | US20060193851 Human anti-factor IX/IXa antibodies |
| 08/31/2006 | US20060193848 Mammalian tumor susceptibility genes and their uses |
| 08/31/2006 | US20060193776 Screening methods employing zebrafish and the blood brain barrier |
| 08/31/2006 | US20060193770 Bioassay of measuring tyrosine-kinase ligand, tumor necrosis factor and transforming growth factor level, before administering the myelosuppressive agent to the patient; use in optimizing treatment and avoiding toxic effects |
| 08/31/2006 | US20060193750 Electrochemical detection of explosives in air |
| 08/31/2006 | US20060193749 Transmitting a unique radio frequency (RF) signal in response to a toxic or non-toxic breath sample; and to control a horn and lights of a vehicle, to immobilize the engine |
| 08/31/2006 | US20060193747 Flow analysis system capable of measuring element in sample quantitatively or semi quantitatively |
| 08/31/2006 | US20060193583 Photonic bandgap fibers |
| 08/31/2006 | US20060192121 Infrared Imaging for Evaluation of Corrosion Test Coupons |
| 08/31/2006 | US20060191954 Liquid beverage conductivity detecting system |